In this episode the hosts dive into a $4.5M, 12‑bed Los Angeles drug and alcohol rehab facility deal with $4M revenue and $1M SDE, unpacking utilization trends, regulatory risks (MSO/CPOM), and why it might not be a compelling acquisition as‑is.

Business Listing – https://www.bizbuysell.com/business-opportunity/drug-and-alcohol-rehabilitation-facilities/2447669/

Welcome to Acquisitions Anonymous – the #1 podcast for small business M&A. Every week, we break down businesses for sale and talk about buying, operating, and growing them.

💰 Sponsored by:
Go High Level – The all-in-one sales and marketing platform built for agencies and entrepreneurs. Automate, manage, and grow your business at https://www.gohighlevel.com

Tonnesen Accounting Services - Tonnesen provides full quality of earnings reports trusted by buyers, lenders, and brokers on over $500 million in deals each year. Fast, detailed, and affordable. Visit tonnesenaccountingservices.com or connect with Josh Tonnesen on LinkedIn for a free consult.

In this episode of Acquisitions Anonymous, Bill D’Alessandro, Heather Endresen, Mills Snell, and Chelsea Wood break down a mid‑market drug and alcohol rehabilitation business in Los Angeles County listed for $4.5M with about $4M in annual revenue and $1M in SDE. The business operates two licensed detox and residential facilities with 12 beds, offers a spectrum of evidence‑based therapies (CBT, DBT, EMDR, family therapy), and maintains Joint Commission accreditation and DHCS licensing. While the model appears scalable with high‑margin services, the panel highlights concerning utilization trends and forecasting assumptions baked into the seller’s projections.

Key Highlights:
- Deal Specifics: 12‑bed rehab facility in LA County, $4M revenue, $1M SDE, $4.5M asking price.
- Utilization Trends: Declining from ~78% to ~53% with optimistic future forecast that seems questionable.
- Regulatory Risk: Corporate practice of medicine/state licensure complexity in California (MSO workaround concerns).
- Payer Mix & Revenue Drivers: High average daily revenue per patient but mixed insurance/private pay impacts lender appetite.
- Consensus Verdict: Thumbs down for this deal — regulatory friction, utilization risks, and mid‑market performance dampen attractiveness.

Subscribe to weekly our Newsletter and get curated deals in your inbox

Advertise with us by clicking here

• Do you love Acquanon and want to see our smiling faces? Subscribe to our Youtube channel.
• Do you enjoy our content? Rate our show!
• Follow us on Twitter @acquanon Learnings about small business acquisitions and operations.

For inquiries or suggestions, email us at contact@acquanon.com

Interested in buying a franchise? Check out Connor's website here: https://connorgroce.com/lander

Come to HoldCo Conference for business owners, Feb 9-11 → https://links.girdley.com/hcc-yt

In this rerun episode, the hosts revisit a $65K Utah Christmas tree lot deal and debate whether this nostalgic seasonal hustle is worth the location headaches and short sales window.

Welcome to Acquisitions Anonymous – the #1 podcast for small business M&A. Every week, we break down businesses for sale and talk about buying, operating, and growing them.

Subscribe for more episodes: https://www.youtube.com/@AcquisitionsAnonymousPodcast?sub_confirmation=1

Subscribe to our Newsletter: https://www.acquanon.com/newsletter

Connect with us on Social Media:
Twitter: https://twitter.com/acquanon
LinkedIn: https://www.linkedin.com/company/acquanon

👋 Follow the Hosts
Michael Girdley – Entrepreneur & investor. Twitter: https://twitter.com/girdley
Bill D’Alessandro – CEO of Elements Brands. Twitter: https://twitter.com/BillDA
Heather Endresen – SBA lending expert & advisor. Twitter: https://twitter.com/EndresenHeather
Mills Snell – Small business investor & advisor. Twitter: https://twitter.com/thegeneralmills

We’re bringing back a listener favorite: a seasonal Christmas tree lot in Southern Utah County listed for $65K, with $29K in cash flow on $85K in revenue. It includes $2K in equipment, $1,750 in inventory, and seller financing at 5%.

With 10+ years in business and a loyal customer base, it sounds promising—until you find out there's no guaranteed location or lease. That one detail sparks a lively debate on whether this is a low-risk side hustle or a logistically doomed venture.

Michael, Bill, and Heather break down the seasonal business model, the importance of location in retail, and whether this business is worth buying—or just replicating from scratch.

Subscribe to weekly our Newsletter and get curated deals in your inbox

Advertise with us by clicking here

• Do you love Acquanon and want to see our smiling faces? Subscribe to our Youtube channel.
• Do you enjoy our content? Rate our show!
• Follow us on Twitter @acquanon Learnings about small business acquisitions and operations.

For inquiries or suggestions, email us at contact@acquanon.com

In this episode the hosts dig into a $7.1 M cash‑price listing for a specialty pharmacy in Beverly Hills — evaluating its 1.49 M EBITDA, market position and regulatory complexity to see whether it’s a viable acquisition.

Business Listing – https://www.bizbuysell.com/business-opportunity/specialty-medical-pharmacy-in-prime-southern-california-location/2445305/

Welcome to Acquisitions Anonymous – the #1 podcast for small business M&A. Every week, we break down businesses for sale and talk about buying, operating, and growing them.

💰 Sponsored by:
Tonnesen Accounting Services - Tonnesen provides full quality of earnings reports trusted by buyers, lenders, and brokers on over $500 million in deals each year. Fast, detailed, and affordable. Visit tonnesenaccountingservices.com or connect with Josh Tonnesen on LinkedIn for a free consult.

Capital Pad – A platform connecting accredited investors with vetted small business acquisition deals. Discover exclusive opportunities at https://capitalpad.com

This episode of Acquisitions Anonymous breaks down a real‑world potential buy of a specialty (medical) pharmacy based in Beverly Hills, California. The listing claims a 2025 expected revenue of about $6.2 M with $1.49 M in EBITDA/SDE, monthly rent around $9,167, and an asking price of $7.1 M — roughly 4.75× trailing earnings. The sellers are motivated by acute health issues and retirement, which introduces urgency. The hosts explore both the upside — a long‑established business in a wealthy market, high margins, and niche specialty‑pharmacy demand — and the downsides: regulatory/licensure hurdles, dependence on skilled pharmacists, insurance/payer access challenges, and the uncertainty of consistency in earnings.

Key Highlights:
- Asking price: $7.1 M cash, with stated EBITDA/SDE of $1.49 M → ~4.75× multiple.
- Business profile: Long‑established (since ~1980), located in affluent Beverly Hills, servicing specialty prescriptions (potentially high‑cost biologics, pain, immunology, chemo) rather than typical retail offerings.
- Opportunity: High margins (claimed ~25%) — above what might be expected for a typical low‑margin compounding pharmacy.
- Risks: Regulatory/licensure risk under the California pharmacy law: any change in ownership or control requires approval by the board before the transaction can close.
- Execution risk: Because the seller is reportedly ill and likely a “forced seller,” there may be pressure to close quickly — which compresses time for due diligence on payer contracts, referral sources, license transfers, and underlying quality-of-earnings.

Subscribe to weekly our Newsletter and get curated deals in your inbox

Advertise with us by clicking here

• Do you love Acquanon and want to see our smiling faces? Subscribe to our Youtube channel.
• Do you enjoy our content? Rate our show!
• Follow us on Twitter @acquanon Learnings about small business acquisitions and operations.

For inquiries or suggestions, email us at contact@acquanon.com